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database used would require optimization with addition of 
reference spectra for the organism and its close relatives 
(e.g., B. thailandensis). B. pseudomallei, although differ-
ent from other Burkholderia spp. in its pathogenicity and 
epidemiology, is not easily discriminated from B. thailand-
ensis or B. cepacia complex by using phenotypic tests (10).
In summary, infection with B. pseudomallei should be 
considered in patients with pneumonia after travel to the 
Baja Peninsula in Mexico, and especially after an extreme 
weather event. Because of risk for transmission to laborato-
ry workers and the potential for B. pseudomallei to be used 
for bioterrorism, clinical laboratories should perform only 
limited work up of suspected isolates before referring them 
to a public health laboratory for definitive identification.
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To the Editor: Zika virus (ZIKV) is a mosquito-
borne flavivirus related to yellow fever virus, dengue virus 
(DENV), and West Nile virus (WNV). It is a single-strand-
ed positive RNA virus (10,794-nt genome) that is closely 
related to the Spondweni virus and is transmitted by many 
Aedes spp. mosquitoes, including Ae. africanus, Ae. lu-
teocephalus, Ae. hensilli, and Ae. aegypti. The virus was 
identified in rhesus monkeys during sylvatic yellow fever 
surveillance in the Zika Forest in Uganda in 1947 and was 
reported in humans in 1952 (1).
In 2007, an outbreak of ZIKV was reported in Yap Is-
land, Federated States of Micronesia (2). ZIKV also caused 
a major epidemic in the French Polynesia in 2013–2014 (3), 
and New Caledonia reported imported cases from French 
Polynesia in 2013 and reported an outbreak in 2014 (4).
A new challenge has arisen in Brazil with the emer-
gence of ZIKV and co-circulation with others arboviruses 
(i.e., DENV and chikungunya virus [CHIKV]). We report 
ZIKV infection in Brazil associated with a recent ongoing 
outbreak in Camaçari, Bahia, Brazil, of an illness charac-
terized by maculopapular rash, fever, myalgias/arthralgia, 
and conjunctivitis.
On March 26, 2015, serum samples were obtained 
from 24 patients (Table) at Santa Helena Hospital in Cama-
çari who were given a presumptive diagnosis of an acute 
viral illness by emergency department physicians. These 
patients were given treatment for a dengue-like illness, and 
blood samples were obtained for complete blood counts 
and serologic testing by using an ELISA specific for IgG 
and IgM against DENV.
Serum samples were analyzed at the Federal Univer-
sity of Bahia by reverse transcription PCR (RT-PCR) to 
detect DENV, CHIKV, WNV, Mayaro virus, and ZIKV. 
In brief, serum samples were subjected to RNA extrac-
tion by using the QIAamp Viral RNA Mini Kit (QIAGEN, 
Hilden, Germany). RNA was reverse transcribed by using 
the SuperScript II Reverse Transcription Kit (Invitrogen, 
Carlsbad, CA, USA) and subjected to PCRs specific for 
DENV (5) CHIKV (6), WNV (7) and Mayaro virus (8). 
A positive RT-PCR for a partial region of the envelope 
gene with primers ZIKVENF and ZIKVENVR (positions 
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1538–1558 and 1902–1883, respectively) (9) was consid-
ered indicative of ZIKV infection. PCR products (362 bp) 
were sequenced at the ACTGene Analises Moleculares, Al-
vorada, Rio Grande do Sul (Porto Allegre, Brazil), and se-
quences were deposited in GenBank under accession nos. 
KR816333–KR816336.
All patients were negative by RT-PCR for DENV, 
Mayaro virus, and WNV. Samples from 7 (29.2%) patients 
were positive by RT-PCR for ZIKV (369-bp fragment) and 
from 3 (12.5%) patients for CHIKV (305-bp fragment). 
There was no simultaneous detection of ZIKV and CHIKV. 
Most (85.7%) patients positive for ZIKV were women; they 
had a median age of 28 years and no history of international 
travel. Patients positive for ZIKV sought medical care after a 
4-day (range 1–5 days) history of rash, myalgias, arthralgias, 
or fever. Three patients had IgG against DENV, which is 
consistent with a previous DENV infection, and none of the 
7 ZIKV-positive patients had a positive response for DENV.
Mean laboratory findings for patients with acute 
ZIKV infection were a leukocyte count of 3,750 cells/mm3 
(range 2,790 cells/mm3–6,150 cells/mm3) and a platelet 
count of 180,000 platelets/mm3 (range 151,000 platelets/
mm3–274,000 platelets/mm3). The mean C-reactive protein 
level was 16.3 mg/L (range 0.9 mg/L–19.7 mg/L). Sign and 
symptom duration was 1–5 days, and most patients had a 
maculopapular rash, myalgias, fever, and headache. Ar-
thralgia was seen less frequently.
ZIKV infections were assessed by sequencing par-
tial ZIKV envelope gene regions of isolates. Phylogenetic 
analysis rooted with Spondwei virus showed that ZIKV 
sequences obtained belonged to the Asian lineage and 
showed 99% identity with a sequence from a ZIKV isolate 
from French Polynesia (KJ776791) (10).
We report ZIKV infection in Brazil in association 
with an ongoing outbreak of an acute maculoexantematic 
illness. Although the patient population samples were not 
randomly selected, 42% (10/24) of the patients were posi-
tive for ZIKV (n = 7) or CHIKV (n = 3) and had macu-
lopapular rash, fever, myalgias and headache. After detec-
tion of ZIKV in Bahia, many cases have been identified 
in other states (http://www.promedmail.org, archive no. 
20152015602.343.1158).
Cases of infection with DENV, CHIKV, and ZIKV in 
Brazil and elsewhere will make diagnosis based on clinical 
and epidemiologic grounds unreliable. These issues show 
the need for laboratory confirmation of these arboviral in-
fections. More studies are needed to address the effects of 
these concurrent arboviruses infections in Brazil.
This study was supported by Fundação de Amparo a Pesquisa do 
Estado da Bahia.
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Table. Characteristics of 24 patients with positive and negative results for infection with Zika virus, Brazil, 2015 
Reverse transcription PCR 
result for Zika virus (no.) 
Mean (SD) patient 
age, y Patient sex, F/M 
No. (%) 
Rash Fever Myalgia Headache 
Positive (7) 33 (15) 6/1 6 (85.7) 3 (43) 4 (57.1) 3 (43) 
Negative (17) 31 (8.5) 12/5 12 (70.6) 6 (35.3) 9 (53) 11 (64.7) 
 
